SCHEMBL28912154

SCHEMBL28912154

C#C[C@H](Cc1ccc(OC)cc1)OC(N)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LDHA P00338 1/20 0.51
▸ SLC6A4 P31645 1/20 0.46
▸ CYP2C19 P33261 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ ACACB O00763 2/20 0.43
▸ POLB P06746 2/20 0.43
▸ DPP4 P27487 1/20 0.42
▸ FAP Q12884 1/20 0.42
▸ DPP8 Q6V1X1 1/20 0.42
▸ DPP9 Q86TI2 1/20 0.42
▸ DPP7 Q9UHL4 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ PPARG P37231 1/20 0.41
▸ PPARA Q07869 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ PARP1 P09874 1/20 0.41
▸ PARP10 Q53GL7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28912156 1.00 LDHA (0.51) LDHASLC6A4CYP2C19CYP1A2CYP2D6
SCHEMBL28558904 0.80 LDHA (0.49) LDHASLC6A4CYP2C19CYP1A2CYP2D6
SCHEMBL28558905 0.80 LDHA (0.49) LDHASLC6A4CYP2C19CYP1A2CYP2D6
SCHEMBL28549063 0.80 LDHA (0.46) LDHAACACBPOLBHTT
SCHEMBL28549393 0.77 LDHA (0.56) LDHASLC6A4CYP2C19CYP1A2CYP2D6
SCHEMBL28562541 0.76 LDHA (0.54) LDHASLC6A4CYP2C19CYP1A2CYP2D6
SCHEMBL28570428 0.75 LDHA (0.53) LDHASLC6A4CYP2C19CYP1A2CYP2D6
SCHEMBL28562317 0.74 LDHA (0.49) LDHASLC6A4CYP2C19CYP1A2CYP2D6
SCHEMBL28562316 0.74 LDHA (0.49) LDHASLC6A4CYP2C19CYP1A2CYP2D6
SCHEMBL28912151 0.73 LDHA (0.51) LDHASLC6A4CYP2C19CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107848962-B Urea derivative or pharmacologically acceptable salt thereof 杏林制药株式会社 2021-04-09 — — CN disclosed
Send feedback